Rhabdomyosarcomas do not contain mutations in the DNA binding domains of myogenic transcription factors

11Citations
Citations of this article
9Readers
Mendeley users who have this article in their library.

Abstract

Skeletal myogenesis is regulated by a group of transcription factors (MyoD, myogenin, myf5, and myf6) that are 'basic helix-loop-helix' proteins that bind to the promoters of muscle-specific genes and promote their expression. We have previously shown that after a mutation of Leu122 to Arg the DNA binding basic domain of MyoD confers c-myc-like functional characteristics to the protein. In this study we used single-strand conformation polymorphism analysis to determine whether such mutations occur naturally in rhabdomyosarcomas. We have found that the basic domains of all the myogenic factors remain unaltered in rhabdomyosarcomas. Selection against such mutations may be the result of functional redundancy of these myogenic transcription factors.

Cite

CITATION STYLE

APA

Anand, G., Shapiro, D. N., Dickman, P. S., & Prochownik, E. V. (1994). Rhabdomyosarcomas do not contain mutations in the DNA binding domains of myogenic transcription factors. Journal of Clinical Investigation, 93(1), 5–9. https://doi.org/10.1172/JCI116982

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free